Contraceptives Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2020 to 2025

Published on : Apr-2020 | List of Tables : 48 | List of Figures : 62 | No. of Pages : 170 | Report Code : FACT4719MR | Format :

Rise in Unwanted Pregnancies to Spur Contraceptives Market, Poised to Register Downturn due to COVID-19 Pandemic

Most unwanted pregnancies occur among adolescents and young women. Such pregnancies are a major source of the prevalence of sexually transmitted diseases (STDs) such as HIV, chlamydia, genital herpes and hepatitis B. With this ever-increasing risk, there is a rise in awareness about modern contraceptives. Governments across the world have heavily invested in family planning and sex education programs to spread awareness about the dangers of STDs.

On the back of these trends, the global contraceptives market is set to receive an uptick in the near future. A robust 6.4% CAGR is predicted for the contraceptives market during the forecast period (2020-2025). The market shall surpass a valuation of US$ 37,242.7 Mn by the end of 2025. Other trends, notably the introduction of new, innovative and low cost contraceptive devices by key market players is also expected to significantly leverage the contraceptives market. For instance, Agile Therapeutics is performing a stage 3 trial for Twirla, a contraceptive patch designed to deliver a low daily dose of estrogen.

The COVID-19 pandemic is poised to bring about a downturn in the sales of contraceptives, owing to social distancing and limited physical contact among young people. The global supply of external physical barriers such as condoms shall experience a drop, owing to tighter border restrictions regarding import and export of products and reduced production.

Contraceptive Devices to Acquire Maximum Market Share

The contraceptive devices segment shall contribute to the maximum growth of the contraceptives market. Contraceptive devices are projected to capture more than half of the global contraceptives market during the forecast period. This is attributed to the major side effects of ingesting contraceptive drugs, particularly among women. These include nausea, headache, weight gain, increased bleeding, dysmenorrhea and menstrual changes. Moreover, the introduction of custom-fit condoms by key market players is expected to burgeon the segment’s market share. Projected CAGR for the contraceptive devices segment is pegged at 6.6% during the forecast period.

gobal contraceptives market 02

To access our cutting edge insights, request for a report sample here

North America to Remain Kingpin, Asia-Pacific Expanding Healthily

North America is anticipated to dominate the contraceptives market, in the wake of growing prevalence of unintended pregnancies, rising demand for reversible contraceptives and public sector initiatives to provide funding for family planning and contraception. The region is expected to surpass a valuation of US$ 12,987.4 by 2025. Projected CAGR for the same is pegged at 6.6% during the forecast period.

Asia-Pacific is emerging as a burgeoning market for contraceptives. High incidence of the spread of STDs due to a rapidly expanding population is a key motivator for the expansion of the contraceptives market. Realizing this, governments across the region have initiated awareness campaigns on contraceptives in rural and urban areas. The contraceptives market in the Asia-Pacific is projected to surpass a value of US$ 7,925.7 by the end of 2025, expanding at a CAGR of 6.8%.

global contraceptives market 01

For more regional insights on the contraceptives market, ask an analyst here

Product Research & Development Key Growth Levers of Companies

The global contraceptives market is highly fragmented. Major market players such as Allergen, plc, Pfizer, Inc, Teva Pharmaceutical Industries Ltd., Bayer AG and Janssen Pharmaceutical Company account for half of the total market share. The companies primarily concentrate on product launches in order to broaden their market footprint. Pfizer Inc’s Sayana Press, for instance, is the first injectable contraceptive for women available in the U.K. The company is also in the process of conducting a study evaluating levonorgestrel and ethinyl estradiol as potential oral contraceptives.

Merck & Co, Inc., offers contraceptive care in the form of combined oral pills, vaginal rings, intrauterine devices and sub-dermal implants. Popular products include Cyclessa, Desogen, NuvaRing, Implanon and Nexplanon. Another important player, Cipla, manufactures oral contraceptives named Crisanta. The medicine contains Drospirenone which prevents the fertilization of the egg with the sperm. It also induces hormonal changes contributing to the prevention of pregnancy.

COVID-19 Market Insights:

The outbreak of the novel coronavirus respiratory disease, or COVID-19, has affected millions globally. As the risk of infections grows exponentially, countries are taking heavy precautionary measures to contain the spread of the deadly virus. With people practicing social distancing, physical contact of any kind, be it handshakes, hugs, kisses or sexual intercourse has been significantly restricted. This is anticipated to significantly impact the sales of contraceptive devices during the forecast period. Physical barriers, especially condoms, are anticipated to witness a downturn, owing to shutting down of several production units. In Asia, several Chinese factories were shuttered when the pandemic initially broke out and workers were forced to stay home in order to contain the spread of the infection. Since most condom manufacturers are situated in Asia, the global supply of the physical contraceptive barrier shall be disrupted.

The closing of international borders in the wake of the pandemic has limited delivery flows of contraceptives, essential maternal health medicines and antiretroviral drugs. Fortunately, the healthcare industry has recognized this and key players are bolstering efforts to stave off the negative impact of supply-chain disruptions in the global contraceptives market. The UN Population Fund (UNFPA), in its interim technical brief in March 2020, advocated governments to promote public and private partnership to mobilize the private sector to enhance supplies of sanitary items and medical equipment and redouble efforts to ensure the procurement, provision, appropriate administration and in-country distribution of required sexual and reproductive health products (SRH), continue investing in reproductive and sexual health supply chain and protective clothing for clinical management of COVID-19.

Global Contraceptives Market- Scope of the Report

The recent study by Fact.MR on global contraceptives market offers a 5-year forecast between 2020 and 2025. The study analyzes crucial trends that are currently determining the growth of the global contraceptives market. This report explicates on vital dynamics such as the drivers, restraints and opportunities for key market players along with key stakeholders as well as emerging players associated with the manufacturing of contraceptive devices. The study also provides dynamics that are responsible for influencing the future status of the global contraceptives market over the forecast period.

A detailed assessment of global contraceptives market value chain analysis, business execution, and supply chain analysis across the regional markets has been covered in the report. A list of prominent companies operating in the global contraceptives market along with their product portfolio enhances the reliability of this comprehensive research study.

Global Contraceptives Market: Report Summary

The study offers a comprehensive analysis on diverse features including production capacities, demand, product developments, revenue generation and sales in global contraceptives market across the globe.

A comprehensive estimate on global contraceptives market has been provided through an optimistic scenario as well as a conservative scenario, taking into account the sales of global contraceptives market during the forecast period. Price point comparison by region with global average price is also considered in the study.

Global Contraceptives Market Segmentation

Fact.MR has studied the global contraceptives market with detailed segmentation on the basis product type, distribution channel and key regions.

Product Type

Distribution Channel

Key Regions

Contraceptive drugs (hormonal):

Oral Contraceptives:

Combined Contraceptives

Mini pills

Contraceptive Injectable

Topical Contraceptive Patch

Hospital Pharmacy:

Public

Private

North America

Contraceptive Devices:

Male Contraceptive Devices

Female Contraceptive Devices:

Female Condoms

Contraceptive Diaphragms

Contraceptive Sponges

Contraceptive Vaginal Rings

Intrauterine Devices

Sub-dermal Contraceptive Implants

Non-surgical Permanent Contraception Devices

Independent Pharmacy

Europe

 

Online Platform

Asia Pacific

 

Clinics

Latin America

 

Others

Middle East & Africa

“This taxonomy prepared is confidential and intended exclusively for the individual or entity with whom it is being shared. Reading, disseminating, distributing, or copying this to any party other than addressee(s) is unauthorized and prohibited.”

Global Contraceptives Market: Analysis on Market Size Evaluation

Global contraceptives market has been analyzed for each market segment, in terms of value (US$ Mn).

Market estimates at global and regional levels for contraceptives is available in terms of “US$ Mn” for value, along with market attractiveness evaluation in the report. A Y-o-Y growth contrast on prominent contraceptive devices segments, along with market attractiveness evaluation has been incorporated in the report.

Global Contraceptives Market: Inspected Assessment on Regional Segments

Key sections have been elaborated in the global contraceptives report, which have helped to deliver projection on the regional markets. These chapters include the regional macros (economic and business environment outlook), which are expected to have a momentous influence on the growth of global contraceptives market during the forecast period.

Country-specific valuation on demand for assistive devices has been offered for each regional market, along with the market scope estimate and forecast, price index, and impact analysis of dynamics of prominence in regions and countries. Detailed breakup in terms of value for emerging countries has also been included in the report.

Global Contraceptives Market: In-depth Analysis on Competitive Landscape

The report sheds light on the leading manufacturers of contraceptives along with their detailed profiles. Essential and up-to-date data information related to the market performers, who are principally engaged in the production of contraceptives, has been brought with the help of a detailed dashboard view. Market share analysis and comparison of prominent players provided in the report permits the report readers to take preemptive steps in advancing their businesses.

Company profiles have been included in the report, which includes essentials such as product portfolio, key strategies along with all-inclusive SWOT analysis on each player. Company presence is mapped and presented through the matrix for all the prominent players thus providing the readers with actionable insights, which helps in thoughtfully presenting market status, and predicting the competition level in global contraceptives market. Prominent manufacturers with established market presence in global contraceptives market are Allergen, plc, Pfizer, Inc, Teva Pharmaceutical Industries Ltd., Bayer AG and Janssen Pharmaceutical Company.

1. Preface 

    1.1. Report Scope and Market Segmentation

    1.2. Research Highlights

2. Assumptions and Research Methodology

    2.1. Assumptions and Acronyms Used

    2.2. Research Methodology

3. Executive Summary

    3.1. Global Contraceptive Market Size (US$ Mn) and Forecast, by Region, 2020 and 2025

    3.2. Global Contraceptive Market: Market Snapshot

4. Market Overview

    4.1. Global Contraceptive Market Overview

    4.2. Global Contraceptive Market Key Industry Developments

5. Market Dynamics

    5.1. Drivers and Restraints Snapshot Analysis

    5.2. Drivers

    5.3. Restraints

    5.4. Opportunities

    5.5. Key Trends

    5.6. Global Contraceptive Market Revenue Projections (US$ Mn), 2020–2025

    5.7. Regulatory Framework

    5.8. Heat Map Analysis - Company

6. Global Contraceptive Market Analysis, by Product

    6.1. Introduction

    6.2. Key Insights

    6.3. Global Contraceptive Market Size and Forecast, by Product

        6.3.1. Contraceptive Drugs

            6.3.1.1. Oral Contraceptives

                6.3.1.1.1. Combined Contraceptives

                6.3.1.1.2. Mini-pills

            6.3.1.2. Contraceptive Injectable

            6.3.1.3. Topical Contraceptive Patch

        6.3.2. Contraceptive Injectable

            6.3.2.1. Male Contraceptive Devices

            6.3.2.2. Female Contraceptive Devices

                6.3.2.2.1. Female Condoms

                6.3.2.2.2. Contraceptive Diaphragms

                6.3.2.2.3. Contraceptive Sponges

                6.3.2.2.4. Contraceptive Vaginal Rings

                6.3.2.2.5. Intrauterine Devices

                6.3.2.2.6. Sub-dermal Contraceptives Implants

                6.3.2.2.7. Non-Surgical Permanent Contraception Devices

    6.4. Global Contraceptive Market Analysis, by Product

    6.5. Global Contraceptive Market Attractiveness Analysis, by Product

7. Global Contraceptive Market Analysis, by Distribution Channel

    7.1. Introduction

    7.2. Key Insights

    7.3. Global Contraceptive Market Size and Forecast, by Distribution Channel

        7.3.1. Hospital Pharmacy

            7.3.1.1. Public

            7.3.1.2. Private

        7.3.2. Independent Pharmacy

        7.3.3. Online Platform

        7.3.4. Clinics

        7.3.5. Others

    7.4. Global Contraceptive Market Analysis, by Distribution Channel

    7.5. Global Contraceptive Market Attractiveness Analysis, by Distribution Channel

8. Global Contraceptive Market Analysis, by Region

    8.1. Introduction

    8.2. Key Insights

    8.3. Global Contraceptive Market Size and Forecast , by Region, 2014–2025

        8.3.1. North America

        8.3.2. Europe

        8.3.3. Asia Pacific

        8.3.4. Latin America

        8.3.5. Middle East & Africa

    8.4. Global Contraceptive Market Analysis, by Region

    8.5. Global Contraceptive Market Attractiveness Analysis, by Region

9. North America Contraceptive Market Analysis

    9.1. North America Contraceptive Market Key Findings

    9.2. North America Contraceptive Market Overview

    9.3. North America Contraceptive Market Size and Forecast, by Product

        9.3.1. Contraceptive Drugs

            9.3.1.1. Oral Contraceptives

                9.3.1.1.1. Combined Contraceptives

                9.3.1.1.2. Mini-pills

            9.3.1.2. Contraceptive Injectable

            9.3.1.3. Topical Contraceptive Patch

        9.3.2. Contraceptive Injectable

            9.3.2.1. Male Contraceptive Devices

            9.3.2.2. Female Contraceptive Devices

                9.3.2.2.1. Female Condoms

                9.3.2.2.2. Contraceptive Diaphragms

                9.3.2.2.3. Contraceptive Sponges

                9.3.2.2.4. Contraceptive Vaginal Rings

                9.3.2.2.5. Intrauterine Devices

                9.3.2.2.6. Sub-dermal Contraceptives Implants

        9.3.3. Non-Surgical Permanent Contraception Devices

    9.4. North America Contraceptive Market Size and Forecast, by Distribution Channel

        9.4.1. Hospital Pharmacy

            9.4.1.1. Public

            9.4.1.2. Private

        9.4.2. Independent Pharmacy

        9.4.3. Online Platform

        9.4.4. Clinics

        9.4.5. Others

    9.5. North America Contraceptive Market Forecast, by Country

        9.5.1. U.S.

        9.5.2. Canada

    9.6. North America Contraceptive Market Attractiveness Analysis 

        9.6.1. By Product

        9.6.2. By Distribution Channel

        9.6.3. By Country

10. Europe Contraceptive Market Analysis

    10.1. Europe Contraceptive Market Key Findings

    10.2. Europe Contraceptive Market Overview

    10.3. Europe Contraceptive Market Size and Forecast, by Product

        10.3.1. Contraceptive Drugs

            10.3.1.1. Oral Contraceptives

                10.3.1.1.1. Combined Contraceptives

                10.3.1.1.2. Mini-pills

            10.3.1.2. Contraceptive Injectable

            10.3.1.3. Topical Contraceptive Patch

        10.3.2. Contraceptive Injectable

            10.3.2.1. Male Contraceptive Devices

            10.3.2.2. Female Contraceptive Devices

                10.3.2.2.1. Female Condoms

                10.3.2.2.2. Contraceptive Diaphragms

                10.3.2.2.3. Contraceptive Sponges

                10.3.2.2.4. Contraceptive Vaginal Rings

                10.3.2.2.5. Intrauterine Devices

                10.3.2.2.6. Sub-dermal Contraceptives Implants

        10.3.3. Non-Surgical Permanent Contraception Devices

    10.4. Europe Contraceptive Market Size and Forecast, by Distribution Channel

        10.4.1. Hospital Pharmacy

            10.4.1.1. Public

            10.4.1.2. Private

        10.4.2. Independent Pharmacy

        10.4.3. Online Platform

        10.4.4. Clinics

        10.4.5. Others

    10.5. Europe Contraceptive Market Forecast, by Country

        10.5.1. Germany

        10.5.2. U.K.

        10.5.3. France

        10.5.4. Spain

        10.5.5. Italy

        10.5.6. Rest of Europe

    10.6. Europe Contraceptive Market Attractiveness Analysis

        10.6.1. By Product

        10.6.2. By Distribution Channel

        10.6.3. By Country

11. Asia Pacific Contraceptive Market Analysis

    11.1. Asia Pacific Contraceptive Market Key Findings

    11.2. Asia Pacific Contraceptive Market Overview

    11.3. Asia Pacific Cytometry Market Size and Forecast, by Product

        11.3.1. Contraceptive Drugs

            11.3.1.1. Oral Contraceptives

                11.3.1.1.1. Combined Contraceptives

                11.3.1.1.2. Mini-pills

            11.3.1.2. Contraceptive Injectable

            11.3.1.3. Topical Contraceptive Patch

        11.3.2. Contraceptive Injectable

            11.3.2.1. Male Contraceptive Devices

            11.3.2.2. Female Contraceptive Devices

                11.3.2.2.1. Female Condoms

                11.3.2.2.2. Contraceptive Diaphragms

                11.3.2.2.3. Contraceptive Sponges

                11.3.2.2.4. Contraceptive Vaginal Rings

                11.3.2.2.5. Intrauterine Devices

                11.3.2.2.6. Sub-dermal Contraceptives Implants

        11.3.3. Non-Surgical Permanent Contraception Devices

    11.4. Asia Pacific Contraceptive Market Size and Forecast, by Distribution Channel

        11.4.1. Hospital Pharmacy

            11.4.1.1. Public

            11.4.1.2. Private

        11.4.2. Independent Pharmacy

        11.4.3. Online Platform

        11.4.4. Clinics

        11.4.5. Others

    11.5. Asia Pacific Contraceptive Market Forecast, by Country

        11.5.1. China

        11.5.2. India

        11.5.3. Japan

        11.5.4. Australia & New Zealand

        11.5.5. Rest of Asia Pacific

    11.6. Asia Pacific Contraceptive Market Attractiveness Analysis 

        11.6.1. By Product

        11.6.2. By Distribution Channel

        11.6.3. By Country

12. Latin America Contraceptive Market Analysis

    12.1. Latin America Contraceptive Market Key Findings

    12.2. Latin America Contraceptive Market Overview

    12.3. Latin America Cytometry Market Size and Forecast, by Product

        12.3.1. Contraceptive Drugs

            12.3.1.1. Oral Contraceptives

                12.3.1.1.1. Combined Contraceptives

                12.3.1.1.2. Mini-pills

            12.3.1.2. Contraceptive Injectable

            12.3.1.3. Topical Contraceptive Patch

        12.3.2. Contraceptive Injectable

            12.3.2.1. Male Contraceptive Devices

            12.3.2.2. Female Contraceptive Devices

                12.3.2.2.1. Female Condoms

                12.3.2.2.2. Contraceptive Diaphragms

                12.3.2.2.3. Contraceptive Sponges

                12.3.2.2.4. Contraceptive Vaginal Rings

                12.3.2.2.5. Intrauterine Devices

                12.3.2.2.6. Sub-dermal Contraceptives Implants

        12.3.3. Non-Surgical Permanent Contraception Devices

    12.4. Latin America Contraceptive Market Size and Forecast, by Distribution Channel

        12.4.1. Hospital Pharmacy

            12.4.1.1. Public

            12.4.1.2. Private

        12.4.2. Independent Pharmacy

        12.4.3. Online Platform

        12.4.4. Clinics

        12.4.5. Others

    12.5. Latin America Contraceptive Market Forecast, by Country

        12.5.1. Brazil

        12.5.2. Mexico

        12.5.3. Rest of Latin America

    12.6. Latin America Contraceptive Market Attractiveness Analysis

        12.6.1. By Product

        12.6.2. By Distribution Channel

        12.6.3. By Country

13. Middle East & Africa Contraceptive Market Analysis

    13.1. Middle East & Africa Contraceptive Market Key Findings

    13.2. Middle East & Africa Contraceptive Market Overview

    13.3. Middle East & Africa Cytometry Market Size and Forecast, by Product

        13.3.1. Contraceptive Drugs

            13.3.1.1. Oral Contraceptives

                13.3.1.1.1. Combined Contraceptives

                13.3.1.1.2. Mini-pills

            13.3.1.2. Contraceptive Injectable

            13.3.1.3. Topical Contraceptive Patch

        13.3.2. Contraceptive Injectable

            13.3.2.1. Male Contraceptive Devices

            13.3.2.2. Female Contraceptive Devices

                13.3.2.2.1. Female Condoms

                13.3.2.2.2. Contraceptive Diaphragms

                13.3.2.2.3. Contraceptive Sponges

                13.3.2.2.4. Contraceptive Vaginal Rings

                13.3.2.2.5. Intrauterine Devices

                13.3.2.2.6. Sub-dermal Contraceptives Implants

        13.3.3. Non-Surgical Permanent Contraception Devices

    13.4. Middle East & Africa Contraceptive Market Size and Forecast, by Distribution Channel

        13.4.1. Hospital Pharmacy

            13.4.1.1. Public

            13.4.1.2. Private

        13.4.2. Independent Pharmacy

        13.4.3. Online Platform

        13.4.4. Clinics

        13.4.5. Others

    13.5. Middle East Contraceptive Market Forecast, by Country

        13.5.1. South Africa

        13.5.2. Saudi Arabia

        13.5.3. U.A.E.

        13.5.4. Rest of Middle East & Africa

    13.6. Middle East Contraceptive Market Attractiveness Analysis 

        13.6.1. By Product

        13.6.2. By Distribution Channel

        13.6.3. By Country

14. Competition Landscape

    14.1. Global Contraceptive Market Share Analysis, by Company (2018)

    14.2. Company Profiles

        14.2.1. Merck & Co., Inc.

            14.2.1.1. Overview (HQ, Employee Strength, Business Segments)

            14.2.1.2. Financials

            14.2.1.3. Recent Developments

            14.2.1.4. Strategy

        14.2.2. Cipla Inc.

            14.2.2.1. Overview (HQ, Employee Strength, Business Segments)

            14.2.2.2. Financials

            14.2.2.3. Recent Developments

            14.2.2.4. Strategy

        14.2.3. Allergan plc

            14.2.3.1. Overview (HQ, Employee Strength, Business Segments)

            14.2.3.2. Financials

            14.2.3.3. Recent Developments

            14.2.3.4. Strategy

        14.2.4. Bayer AG

            14.2.4.1. Overview (HQ, Employee Strength, Business Segments)

            14.2.4.2. Financials

            14.2.4.3. Recent Developments

            14.2.4.4. Strategy

        14.2.5. HLL Lifecare Limited

            14.2.5.1. Overview (HQ, Employee Strength, Business Segments)

            14.2.5.2. Financials

            14.2.5.3. Recent Developments

            14.2.5.4. Strategy

        14.2.6. Mankind Pharma

            14.2.6.1. Overview (HQ, Employee Strength, Business Segments)

            14.2.6.2. Financials

            14.2.6.3. Recent Developments

            14.2.6.4. Strategy

        14.2.7. Pfizer, Inc.

            14.2.7.1. Overview (HQ, Employee Strength, Business Segments)

            14.2.7.2. Financials

            14.2.7.3. Recent Developments

            14.2.7.4. Strategy

        14.2.8. Teva Pharmaceutical Industries Ltd l

            14.2.8.1. Overview (HQ, Employee Strength, Business Segments)

            14.2.8.2. Financials

            14.2.8.3. Recent Developments

            14.2.8.4. Strategy

        14.2.9. Mithra Pharmaceuticals

            14.2.9.1. Overview (HQ, Employee Strength, Business Segments)

            14.2.9.2. Financials

            14.2.9.3. Recent Developments

            14.2.9.4. Strategy

        14.2.10. Janssen Pharmaceutical Company

            14.2.10.1. Overview (HQ, Employee Strength, Business Segments)

            14.2.10.2. Financials

            14.2.10.3. Recent Developments

            14.2.10.4. Strategy

        14.2.11. Reckitt Benckiser Group plc

            14.2.11.1. Overview (HQ, Employee Strength, Business Segments)

            14.2.11.2. Financials

            14.2.11.3. Recent Developments

            14.2.11.4. Strategy

Fact.MR offers custom research services that help clients to get specific research solutions

We are committed towards customer satisfaction and quality service.


Our Clients

Malaysian Cocoa Board
Dunlop International Europe Ltd
Roland Berger
Superior Essex
Commscope
Deloitte

Fact.MR in Media

Contraceptives Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2020 to 2025